Aptevo Therapeutics Inc expected to post a loss of $1.18 a share - Earnings Preview

Aptevo Therapeutics

08/05/2023 19:35

* Aptevo Therapeutics Inc  APVO.OQ   APVO.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 10
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Aptevo Therapeutics
Inc
is for a loss of $1.18 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aptevo
Therapeutics Inc is $14.5​, above​ its last closing price
of $1.72. ​​​

This summary was machine generated May 8 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated